FDA 483 - Sun Pharmaceutical Medicare Limited - February 27, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Sun Pharmaceutical Medicare Ltd., a sterile drug manufacturer in Halol, Gujarat, India, revealed significant deficiencies in preventing microbiological contamination during the manufacturing of sterile drug products. The inspection also cited failures to thoroughly investigate out-of-specification results and atypical events, as well as the use of unqualified production equipment. These observations indicate serious concerns regarding the firm's quality control and manufacturing practices for sterile products.
ID · 6a1d3841-f2ae-4d88-8fee-4aac9873a462